Drugs / C-82
last change Sep 2016 re-read 2 minutes ago

C-82

Developed for
psoriasis · systemic sclerosis
Investigated by
Prism Pharma Co., Ltd.

Trials 1 · a red edge is where a trial was stopped

201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT02432027 Jun → Aug 2015 psoriasis Prism Pharma Co., Ltd. Completed No outcome recorded
Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT02349009 Comparator Jun 2015 → Jul 2016 systemic sclerosis Prism Pharma Co., Ltd. Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as C-82 ClinicalTrials.gov intervention name — accepted as the source's own label NCT02349009
1

NCT02432027

Route Topical “apply the active study medication daily for 4 weeks to either the right or left forearm” NCT02349009